Similarly, we failed to reject the null hypothesis of no change from pre‐ to postintervention for fasted plasma glucose, TAG, FGF21, GLP‐1, serum insulin concentrations, homeostatic model assessment of insulin resistance, or serum osmolality (all P ≥ 0.136; Table 1). This evidence concerns the gene FGF21 and Insulin resistance.